• USA
    • USA
    • Japan
    • China
    • International
  • USD
    • USD
Shopping Cart

An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical Models

Our use of cookies

We use cookies on our website. Some of these are essential to provide services you have asked for. We would also like to set the following types of optional cookies:

Analytics Cookies

These cookies help us to improve our website by collecting and reporting information on how you use it.

We won't set optional cookies unless you enable them. For more detailed information on the cookies we use, please see our Cookie Policy